How a specific protein in blood vessels helps control inflammation in the retina
Endothelial Rap1 restricts inflammation in the retina
This study is looking at how a protein called Rap1B in the cells of your eye's blood vessels helps control inflammation, which is important for people with Diabetic Retinopathy, and aims to find new ways to prevent vision loss by understanding how this protein interacts with other cells in the eye.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Versiti Wisconsin, INC. NIH-funded |
| Lab location | 1 site (Milwaukee, United States) |
| Project ID | NIH-10954669 on NIH RePORTER |
What this research studies
This research investigates the role of endothelial Rap1B, a protein found in blood vessel cells, in managing inflammation in the retina, particularly in the context of Diabetic Retinopathy (DR). The study focuses on how this protein influences the behavior of retinal endothelial cells and their interactions with immune cells, which can lead to vision loss. By understanding these cellular dynamics and the balance between proinflammatory and homeostatic signals, the research aims to identify new therapeutic targets for early intervention in DR. The methodology includes examining the effects of Rap1B on nitric oxide release and its role in signaling pathways that affect blood vessel function in the retina.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with Diabetic Retinopathy or those at risk of developing this condition due to diabetes.
Not a fit: Patients without diabetes or those who do not have any retinal conditions may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that prevent vision loss in patients with Diabetic Retinopathy.
How similar studies have performed: Previous research has shown promising results in targeting similar pathways for treating inflammation-related conditions, suggesting potential for success in this approach.
Where this research is happening
Milwaukee, United States
- Versiti Wisconsin, INC. — Milwaukee, United States (Active)
Researchers
- Principal investigator: Chrzanowska, Magdalena — Versiti Wisconsin, INC.
- Study coordinator: Chrzanowska, Magdalena
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.